Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Mar. 31, 2013
Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net earnings $ 84,150 $ 85,090
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 9,279 9,366
Costs recognized on sale of acquired inventory 3,496 5,870
Deferred income taxes (2,054) (7,753)
Stock-based compensation expense 1,374 1,389
Excess tax benefit from stock option exercises (69) (51)
Impairment losses on investments 0 3,254
Losses by equity method investees 114 558
Other 337 (10)
Change in operating assets and operating liabilities:    
Trade accounts and other receivables (2,319) (4,645)
Inventories (2,032) (1,586)
Prepaid expenses (240) (393)
Trade accounts payable and accrued expenses (215) 1,641
Salaries, wages and related accruals 636 1,351
Income taxes payable 1,118 (4,748)
Net cash provided by operating activities 93,575 89,333
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of available-for-sale investments (89,099) (124,007)
Proceeds from sales of available-for-sale investments 26,367 53,931
Proceeds from maturities of available-for-sale investments 53,987 56,273
Additions to property and equipment (17,108) (4,884)
Increase in other long-term assets (592) (489)
Distribution from unconsolidated entity 0 42
Net cash used in investing activities (26,445) (19,134)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Cash dividends (32,413) (30,707)
Proceeds from stock option exercises 824 667
Excess tax benefit from stock option exercises 69 51
Purchase of common stock for stock bonus plans (573) (907)
Repurchase of common stock 0 (21,283)
Net cash used in financing activities (32,093) (52,179)
Effect of exchange rate changes on cash and cash equivalents (999) (353)
Net increase in cash and cash equivalents 34,038 17,667
Cash and cash equivalents at beginning of period 116,675 77,613
Cash and cash equivalents at end of period $ 150,713 $ 95,280